Literature DB >> 2526093

Measuring comorbidity and overlap in the hospitalization cost for alcohol and drug abuse and mental illness.

D P Rice, S Kelman.   

Abstract

This paper measures the cost of short-stay hospitalization in 1985 for alcohol and drug abuse and mental illness (ADM). We identify and quantify two measurement problems: comorbidity in which ADM disorders may play a secondary role to other diagnoses and "overlap" in which ADM disorders occur together. Using data from the National Hospital Discharge Survey, we estimate the ADM short-stay hospital costs to total $13.1 billion. Almost four-fifths are costs of care for patients with primary ADM diagnoses and the remaining one-fifth is attributed to ADM comorbidity. About one-fifth of both the ADM discharges and the days of care represent overlap for hospitalized patients.

Entities:  

Mesh:

Year:  1989        PMID: 2526093

Source DB:  PubMed          Journal:  Inquiry        ISSN: 0046-9580            Impact factor:   1.730


  5 in total

1.  A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults.

Authors:  Lisa A Marsch; Sarah K Moore; Jacob T Borodovsky; Ramon Solhkhah; Gary J Badger; Shelby Semino; Kate Jarrett; Kathleen DiGangi Condon; Kate Rossettie; Phillip Vincent; Neda Hajizadeh; Elizabeth Ducat
Journal:  Addiction       Date:  2016-04-21       Impact factor: 6.526

2.  Supplemental Security Income (SSI), Disability Insurance (DI), and substance abusers.

Authors:  C R Gresenz; K Watkins; D Podus
Journal:  Community Ment Health J       Date:  1998-08

3.  Trends in the US prevalence of drug-using parturient women and drug-affected newborns, 1979 through 1990.

Authors:  M Dicker; E A Leighton
Journal:  Am J Public Health       Date:  1994-09       Impact factor: 9.308

4.  Alcohol drinking patterns and medical care use in an HMO setting.

Authors:  D P Rice; C Conell; C Weisner; E M Hunkeler; B Fireman; T W Hu
Journal:  J Behav Health Serv Res       Date:  2000-02       Impact factor: 1.505

5.  A patient-based analysis of drug disorder diagnoses in the Medicare population.

Authors:  W S Cartwright; L M Ingster
Journal:  Health Care Financ Rev       Date:  1993
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.